Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Oct 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 92,203 | 513,140 | 99,492 | 98,654 | 167,046 |
| General And Administrative Expense | 89,010 | 466,912 | 61,362 | 80,266 | 144,961 |
| Other Operating Expenses | 4,409 | 23,455 | 15,103 | 8,059 | 5,472 |
| Operating Expense | 96,612 | 536,595 | 114,595 | 106,713 | 172,518 |
| Operating Income | -96,612 | -536,595 | -114,595 | -106,713 | -172,518 |
| EBIT | -96,612 | -536,595 | -114,595 | -106,713 | -172,518 |
| Interest Income | 65,696 | -- | -- | 0.00 | -- |
| Interest Income Non Operating | 65,696 | -- | -- | 0.00 | -- |
| Net Interest Income | 65,696 | -- | -- | 0.00 | -- |
| Other Income Expense | -109,625 | -4.5M | -679,935 | 983,667 | -52,403 |
| Other Non Operating Income Expenses | -- | -16,072 | 16,072 | 13,667 | -- |
| Special Income Charges | 0.00 | -4.8M | 0.00 | 570,000 | 0.00 |
| Gain On Sale Of Security | -109,625 | 314,367 | -696,007 | 400,000 | -52,403 |
| Pretax Income | -140,541 | -5.0M | -794,530 | 876,954 | -224,921 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 145,500 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -140,541 | -5.0M | -794,530 | 876,954 | -224,921 |
| Net Income From Continuing Operation Net Minority Interest | -140,541 | -5.0M | -794,530 | 876,954 | -224,921 |
| Net Income Including Noncontrolling Interests | -140,541 | -5.0M | -794,530 | 876,954 | -224,921 |
| Net Income Common Stockholders | -140,541 | -5.0M | -794,530 | 876,954 | -224,921 |
| Net Income | -140,541 | -5.0M | -794,530 | 876,954 | -224,921 |
| EBITDA | -96,612 | -536,595 | -114,595 | -106,713 | -172,518 |
| Normalized EBITDA | 13,013 | 3.9M | 581,412 | -1.1M | -120,115 |
| Basic EPS | -0.01 | -- | -0.16 | -0.18 | -0.01 |
| Diluted EPS | -0.01 | -- | -0.16 | -0.18 | -0.01 |
| Basic Average Shares | 17.3M | -- | 4.8M | 4.8M | 4.8M |
| Diluted Average Shares | 17.3M | -- | 4.8M | 4.8M | 4.8M |
| Total Unusual Items | -109,625 | -4.4M | -696,007 | 970,000 | -52,403 |
| Total Unusual Items Excluding Goodwill | -109,625 | -4.4M | -696,007 | 970,000 | -52,403 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 |
| Normalized Income | -30,916 | -552,667 | -98,523 | 52,454 | -172,518 |
| Diluted NI Availto Com Stockholders | -140,541 | -5.0M | -794,530 | 876,954 | -224,921 |
| Gain On Sale Of Ppe | 0.00 | -20,000 | 0.00 | 570,000 | 0.00 |
| Net Income Continuous Operations | -140,541 | -5.0M | -794,530 | 876,954 | -224,921 |
| Net Non Operating Interest Income Expense | 65,696 | -- | -- | 0.00 | -- |
| Other Gand A | 89,010 | 140,062 | 61,362 | 80,266 | 84,811 |
| Salaries And Wages | 0.00 | 326,850 | 0.00 | 0.00 | 60,150 |
| Selling And Marketing Expense | 3,193 | 46,228 | 38,130 | 18,388 | 22,085 |
| Total Expenses | 96,612 | 536,595 | 114,595 | 106,713 | 172,518 |
| Line Item | Q4 2025Oct 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 1.8M | 1.8M | 614,196 | 427,647 | 445,409 |
| Cash Cash Equivalents And Short Term Investments | 1.9M | 2.1M | 765,196 | 1.5M | 535,409 |
| Cash Financial | 1.8M | 1.8M | 614,196 | 427,647 | 445,409 |
| Other Short Term Investments | 82,625 | 220,000 | 151,000 | 1.1M | 90,000 |
| Receivables | 48,409 | 19,937 | 11,733 | 8,183 | 25,333 |
| Prepaid Assets | 0.00 | 20,000 | 30,149 | 245,782 | 263,615 |
| Current Assets | 1.9M | 2.1M | 807,078 | 1.7M | 824,357 |
| Net PPE | 0.00 | 0.00 | 4.7M | 4.7M | 4.7M |
| Total Non Current Assets | 0.00 | 0.00 | 4.7M | 4.7M | 4.7M |
| Total Assets | 1.9M | 2.1M | 5.5M | 6.5M | 5.6M |
| Payables And Accrued Expenses | 30,397 | 77,963 | 132,280 | 272,135 | 217,716 |
| Current Liabilities | 30,397 | 77,963 | 132,280 | 272,135 | 217,716 |
| Other Non Current Liabilities | -- | -- | -- | -- | 13,667 |
| Total Non Current Liabilities Net Minority Interest | 300.00 | 0.00 | 0.00 | 0.00 | 13,667 |
| Total Liabilities Net Minority Interest | 30,697 | 77,963 | 132,280 | 272,135 | 231,383 |
| Common Stock | 18.6M | 18.5M | 17.3M | 17.3M | 17.3M |
| Capital Stock | 18.6M | 18.5M | 17.3M | 17.3M | 17.3M |
| Retained Earnings | -18.2M | -18.0M | -13.0M | -12.3M | -13.1M |
| Gains Losses Not Affecting Retained Earnings | 1.5M | 1.5M | 1.2M | 1.2M | 1.2M |
| Common Stock Equity | 1.9M | 2.0M | 5.4M | 6.2M | 5.3M |
| Stockholders Equity | 1.9M | 2.0M | 5.4M | 6.2M | 5.3M |
| Total Equity Gross Minority Interest | 1.9M | 2.0M | 5.4M | 6.2M | 5.3M |
| Total Capitalization | 1.9M | 2.0M | 5.4M | 6.2M | 5.3M |
| Net Tangible Assets | 1.9M | 2.0M | 5.4M | 6.2M | 5.3M |
| Tangible Book Value | 1.9M | 2.0M | 5.4M | 6.2M | 5.3M |
| Working Capital | 1.9M | 2.0M | 674,798 | 1.5M | 606,641 |
| Invested Capital | 1.9M | 2.0M | 5.4M | 6.2M | 5.3M |
| Share Issued | 17.3M | 17.0M | 4.8M | 4.8M | 4.8M |
| Ordinary Shares Number | 17.3M | 17.0M | 4.8M | 4.8M | 4.8M |
| Notes Receivable | 25,000 | -- | -- | -- | -- |
| Taxes Receivable | 23,409 | 19,937 | 11,733 | 8,183 | 25,333 |
| Line Item | Q4 2025Oct 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 | Q3 2024Jul 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -37,262 | -278,190 | -26,293 | -353,608 | -4,765 |
| Cash Flow From Continuing Operating Activities | -37,262 | -278,190 | -26,296 | -17,310 | -341,060 |
| Stock Based Compensation | 0.00 | 326,850 | 0.00 | 0.00 | 60,150 |
| Change In Working Capital | -6,346 | -52,373 | 72,227 | 89,403 | -228,690 |
| Change In Receivables | -4,316 | -8,204 | -3,550 | 17,150 | -4,765 |
| Change In Payables And Accrued Expense | -2,030 | -54,318 | -139,856 | 54,420 | 15,297 |
| Other Non Cash Items | -- | 0.00 | 3.00 | -- | -- |
| Capital Expenditure | -- | -450.00 | -151.00 | -295,450 | -47,449 |
| Purchase Of PPE | -- | -450.00 | -303,550 | 7,949 | -47,449 |
| Net PPE Purchase And Sale | -- | -450.00 | -303,550 | 7,949 | -47,449 |
| Purchase Of Investment | -- | -- | -- | -- | 0.00 |
| Sale Of Investment | 0.00 | 225,367 | 212,993 | 0.00 | 50,099 |
| Net Investment Purchase And Sale | 0.00 | 225,367 | 212,993 | 0.00 | 50,099 |
| Investing Cash Flow | -25,000 | 224,917 | 212,842 | -450.00 | -292,350 |
| Cash Flow From Continuing Investing Activities | -25,000 | 224,917 | 212,842 | -295,450 | 2,650 |
| Issuance Of Capital Stock | -- | 1.3M | 0.00 | 0.00 | 0.00 |
| Net Common Stock Issuance | -- | 1.3M | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | 1.3M | 0.00 | 0.00 | 0.00 |
| Cash Flow From Continuing Financing Activities | 0.00 | 1.3M | 0.00 | 0.00 | 0.00 |
| Changes In Cash | -62,262 | 1.2M | 186,549 | -17,763 | -633,410 |
| Beginning Cash Position | 1.9M | 614,196 | 427,647 | 445,410 | 1.1M |
| End Cash Position | 1.8M | 1.8M | 614,196 | 427,647 | 445,410 |
| Free Cash Flow | -37,262 | -278,640 | -26,444 | -649,058 | -52,214 |
| Income Tax Paid Supplemental Data | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Interest Paid Supplemental Data | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Asset Impairment Charge | -- | 4.7M | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Reported | -- | -- | -- | -- | -295,000 |
| Change In Prepaid Assets | 0.00 | 10,149 | 215,633 | 17,833 | -239,222 |
| Common Stock Issuance | -- | 1.3M | 0.00 | 0.00 | 0.00 |
| Gain Loss On Investment Securities | 0.00 | 8,550 | -27,743 | 0.00 | -5,539 |
| Gain Loss On Sale Of PPE | -- | 20,000 | 0.00 | -570,000 | 0.00 |
| Net Income From Continuing Operations | -140,541 | -5.0M | -794,530 | 876,954 | -224,921 |
| Net Other Investing Changes | -- | -- | -- | -- | -295,000 |
| Operating Gains Losses | 0.00 | 28,550 | -27,743 | -570,000 | -5,539 |
| Proceeds From Stock Option Exercised | 0.00 | -- | -- | 0.00 | -- |
| Unrealized Gain Loss On Investment Securities | 109,625 | -322,917 | 723,750 | -400,000 | 57,940 |